WHO ICTRP trial
evaluate the safety and immunomodulatory efficacy of Byolic CC supplement
IRCT20240304061158N4 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20240304061158N4 |
|---|---|
| Public title | evaluate the safety and immunomodulatory efficacy of Byolic CC supplement |
| Scientific title | A Clinical trial to evaluate the safety and immunomodulatory efficacy of Byolic CC supplement compared to placebo in healthy adults |
| Primary sponsor | Behpad Teb Iranian |
| Secondary sponsors | Shahed university Immune Response Regulation Research Center |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 1-2 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Immunomodulatory effect on healthy volunteers. |
| Interventions | Intervention 1: Intervention group: healthy volunteers take Byolic CC capsules produced by Behpad Tab for 2 months, once a day, preferably with meals. Intervention 2: Control group: healthy volunteers take placebo capsules produced by… |
| Registration date | Aug 22, 2024 |
| Target size | 90 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: